“Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer: Myth or Reality?”. 2025. Canadian Diabetes & Endocrinology Today 3 (1): 17–22. https://doi.org/10.58931/cdet.2025.3137.